IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 3 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,364,443 | +11.3% | 228,493 | +0.9% | 3.08% | +57.1% |
Q2 2023 | $9,311,128 | +42.5% | 226,493 | +23.9% | 1.96% | -10.5% |
Q1 2023 | $6,532,307 | +17.5% | 182,773 | +22.8% | 2.19% | +4.1% |
Q4 2022 | $5,557,941 | -15.6% | 148,807 | 0.0% | 2.11% | -11.9% |
Q3 2022 | $6,589,000 | -1.2% | 148,807 | -17.4% | 2.39% | +8.4% |
Q2 2022 | $6,668,000 | -0.0% | 180,107 | 0.0% | 2.21% | +49.8% |
Q1 2022 | $6,671,000 | -65.3% | 180,107 | -71.4% | 1.48% | -61.4% |
Q4 2021 | $19,246,000 | – | 630,199 | – | 3.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |